Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 3 , Pages 471-477 , June 2010

Cholesterol succinyl chitosan anchored liposomes: preparation, characterization, physical stability, and drug release behavior

  • Yinsong Wang, MD

      Affiliations

    • College of Pharmacy, Tianjin Medical University, Tianjin, People's Republic of China
    • Corresponding Author InformationCorresponding author: College of Pharmacy, Tianjin Medical University, Tianjin 300070, People's Republic of China.
  • ,
  • Shaoli Tu, MS

      Affiliations

    • Institute of Biomedical Engineering, Chinese Academy of Medical Science, Peking Union Medical College, Tianjin, People's Republic of China
  • ,
  • Rongshan Li, MS

      Affiliations

    • College of Pharmacy, Tianjin Medical University, Tianjin, People's Republic of China
  • ,
  • XiaoYing Yang, PhD

      Affiliations

    • College of Pharmacy, Tianjin Medical University, Tianjin, People's Republic of China
  • ,
  • Lingrong Liu, MD

      Affiliations

    • Institute of Biomedical Engineering, Chinese Academy of Medical Science, Peking Union Medical College, Tianjin, People's Republic of China
  • ,
  • Qiqing Zhang, PhD

      Affiliations

    • Institute of Biomedical Engineering, Chinese Academy of Medical Science, Peking Union Medical College, Tianjin, People's Republic of China
    • Research Center of Biomedical Engineering Medical School Xiamen University, Xiamen, People's Republic of China

Received 2 June 2009 ,Accepted 16 September 2009.

References 

  1. Gregoriadis G. Antimicrob J. Overview of liposomes. J Antimicrob Chemoth. 1991;28:39–48
  2. Park YS, Maruyama K, Huang L. Some negatively charged phospholipids derivatives prolong the liposome circulation in vivo. Biochim Biophys Acta. 1992;1108:257–260
  3. Lukyanov AN, Elbayoumi TA, Chakilam AR, Torchilin VP. Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. J Controlled Release. 2004;100:135–144
  4. Sharma A, Sharma US. Liposomes in drug delivery: progress and limitations. Int J Pharm. 1997;154:123–140
  5. Garg M, Dutta T, Jain NK. Stavudine-loaded O-palmitoyl-anchored carbohydrate-coated liposomes. AAPS PharmSciTech. 2007;8:E86–E93
  6. Matsukawa S, Yamamoto M, Ichinose K, Akiyoshi K, Sunamoto J. Selective uptake by cancer cells of liposomes coated with polysaccharides bearing 1-aminolactose. Anticancer Res. 2000;20:2339–2344
  7. Cheng J, Zhu JB, Yang SX, Wang CB. Preparation of amylopectin modified dipyridamole liposome and its tissue distribution in mice. Acta Pharm Sinica. 2006;41:277–281
  8. Cheng J, Zhu JB, Wen N, Xiong F. Stability and pharmacokinetic studies of O-palmitoyl amylopectin anchored dipyridamole liposomes. Int J Pharm. 2006;313:136–143
  9. Sihorkar V, Vyas SP. Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization. J Pharm Pharm Sci. 2001;4:138–158
  10. Kang EC, Aklyoshi K, Sunamoto J. Surface coating of liposomes with hydrophobized polysaccharides. J Bioact Compat Polym. 1997;12:14–26
  11. Fini A, Orienti I. The role of chitosan in drug delivery: current and potential applications. Am J Drug Deliv. 2003;1:43–59
  12. Ravi KMNV, Muzzarelli RAA, Muzzarelli C, Sashiwa H, Domb AJ. Chitosan chemistry and pharmaceutical perspectives. Chem Rev. 2004;104:6017–6084
  13. Mourya VK, Inamdar NN. Chitosan-modifications and applications: opportunities galore. React Funct Polym. 2008;68:1013–1051
  14. Wang YS, Liu LR, Weng J, Zhang QQ. Preparation and characterization of self-aggregated nanoparticles of cholesterol-modified O-carboxymethyl chitosan conjugates. Carbohydr Polym. 2007;69:597–606
  15. Chen HF, Fan SR, Hu Y. The determination of substitution degree of carboxymethyl chitosan by colloid titration. J Instr Anal. 2003;22:70–73
  16. Torchilin VP, Weissig V. Liposomes. New York: Oxford University Press; 2003;
  17. Hwang SH, Maitani Y, Qi XR, Takayama K, Nagai T. Remote loading of diclofenac, insulin and FITC-insulin into liposomes by pH and acetate gradient methods. Int J Pharm. 1999;179:85–95
  18. Jain SK, Chourasia MK, Jain AK, Chalasani KB, Soni V, Jain A. Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium. AAPS PharmSciTech. 2005;6:E35–E41
  19. Harrigan PR, Wong KF, Redelmeier TE, Wheeler JJ, Cullis PR. Accumulation of doxorubicin and other lipophilic amines into large unilamellar vesicles in response to transmembrane pH gradients. Biochim Biophys Acta. 1993;1149:329–338
  20. Gilad H, Rivka C, Liliana K, Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of. amphipathic weak bases. Biochim Biophys Acta. 1993;1151:201–215
  21. Zhao Y, Deng YH, Xiao LY, Lei JJ, Wang SN. Study on influencing factors in preparation of vincristine sulfate liposomes by active loading method. Chin Pharm J. 2005;40:1717–1720
  22. Guo J, Ping Q, Jiang G, Huang L, Tong Y. Chitosan-coated liposomes: characterization and interaction with leuprolide. Int J Pharm. 2003;260:167–173
  23. Takeuchi H, Matsui Y, Sugihara H, Yamamoto H, Kawashima Y. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm. 2005;303:160–170
  24. Wu ZH, Ping QN, Lei XM, Li JY, Cai P. Effects of the liposomes coated by chitosan and its derivatives on the gastrointestinal transit of insulin. Acta Pharm Sinica. 2005;40:618–622
  25. Zheng AP, Wang JC, Lu WL, Zhang X, Zhang H, Wang XQ, et al. Thymopentin-loaded pH-sensitive chitosan nanoparticles for oral administration: preparation, characterization, and pharmacodynamics. J Nanosci Nanotechnol. 2006;6:2936–2944
  26. Cersosimo RJ, Hong WK. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. J Clin Oncol. 1986;14:425–439
  27. Bonadonna G, Gianni L, Santoro A, Bonfante V, Bidoli P, Casali P, et al. Drugs ten years later: epirubicin. Ann Oncol. 1993;4:359–369

 This work was supported by the National Natural Science Foundation of China (grant no. 30900303).

PII: S1549-9634(09)00188-9

doi: 10.1016/j.nano.2009.09.005

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 3 , Pages 471-477 , June 2010